SARS-CoV-2-IN-19 structure
|
Common Name | SARS-CoV-2-IN-19 | ||
|---|---|---|---|---|
| CAS Number | 2244991-17-9 | Molecular Weight | 558.66 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C33H38N2O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2-IN-19SARS-CoV-2-IN-19 (Compound 6g) is a potent inhibitor of SARS-CoV-2 with an EC50 of 8.8 μM. SARS-CoV-2-IN-19 shows potent activity against SARS-CoV-2 helicase (nsp13), a highly conserved enzyme, highlighting a potentiality against emerging HCoVs outbreaks. SARS-CoV-2-IN-19 has the potential for the research of infection diseases[1]. |
| Name | SARS-CoV-2-IN-19 |
|---|
| Description | SARS-CoV-2-IN-19 (Compound 6g) is a potent inhibitor of SARS-CoV-2 with an EC50 of 8.8 μM. SARS-CoV-2-IN-19 shows potent activity against SARS-CoV-2 helicase (nsp13), a highly conserved enzyme, highlighting a potentiality against emerging HCoVs outbreaks. SARS-CoV-2-IN-19 has the potential for the research of infection diseases[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C33H38N2O6 |
|---|---|
| Molecular Weight | 558.66 |